TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

13.30$ +0.4% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

Amarin Corporation PLC (AMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 214 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AMRN
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
22 24 10 11 16 5.0 66 7.4 1.0 0.5 0.5 7.4 – – – – – 26 54 82 130 181 229 430 614 583 369 307 229 214
4.0 2.8 3.7 3.0 4.6 21 30 12 0.1 – – – – 0.6 0.1 0.1 0.5 12 20 28 34 45 55 96 131 121 127 141 147 93
18 22 15 8.2 11 32 35 -4.5 0.9 0.5 0.5 7.4 – – – – – 14 34 54 96 136 175 334 483 462 242 166 81 121
– 20 20 6.3 5.8 4.1 6.2 5.4 3.5 8.9 17 12 13 18 28 22 59 73 50 51 50 47 56 34 39 29 30 22 21 20
35 7.3 9.7 5.3 9.1 33 24 31 9.0 9.8 13 32 28 29 17 23 58 121 79 93 93 112 180 324 113 142 119 89 73 74
36 30 32 11 14 37 69 34 12 19 31 41 28 31 45 44 117 197 130 152 161 182 283 358 502 451 348 222 173 135
-18 -8.1 -11 -7.1 -2.6 -5.1 -33 -39 -11 -19 -31 -32 -28 -30 -45 -44 -117 -182 -96 -98 -66 -46 -108 -24 -20 11 -106 -57 -92 -14
3.3 0.8 24 9.7 5.6 0.8 29 28 46 1.8 4.5 6.5 2.1 8.2 0.0 0.0 18 34 18 20 19 9.8 8.9 6.6 2.6 0.1 0.0 0.0 0.0 0.0
-17 -11 -16 -8.8 -2.1 -4.7 -34 -27 -10 -21 -28 -39 -21 -60 -250 -67 -171 -169 -59 -118 -76 -55 -116 -22 -17 11 -104 -54 -77 -36
-1.1 0.6 0.1 0.0 0.3 0.4 3.5 -7.4 7.3 -0.7 -0.8 -0.8 -0.7 -0.4 -0.5 2.5 9.1 -3.2 -2.8 -3.1 10.0 13 0.1 0.2 0.7 3.6 2.0 5.4 5.0 2.8
-16 -7.7 -29 4.4 2.5 -4.8 -37 -19 3.2 -21 -27 -38 -20 -59 -250 -69 -179 -166 -56 -115 -86 -68 -116 -23 -18 7.7 -106 -59 -82 -39
-17 -5.6 -7.9 -4.8 -0.2 16 -25 -33 -9.9 -19 -30 -38 -18 -55 -250 -67 -152 -135 -40 -97 -57 -44 -107 -15 -13 14 -101 -51 -74 -33

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?